Dronabinol-Acetazolamide Combination for Obstructive Sleep Apnea

Dronabinol-Acetazolamide Combination for Obstructive Sleep Apnea
$3.67IXHL last close Jun 15
77%66%55%Jun 8Jun 9Jun 10Jun 11Jun 12Jun 13Jun 14Jun 15Jun 16Jun 16 • YES 66.4%
Incannex Healthcare Ltd ($IXHL)
$3.67IXHL last close Jun 15
No stock close$3.99$3.66$3.32Jun 8Jun 9Jun 10Jun 11Jun 12Jun 13Jun 14Jun 15Jun 16Jun 8 • IXHL $3.40Jun 9 • IXHL $3.67Jun 10 • IXHL $3.91Jun 11 • IXHL $3.82Jun 12 • IXHL $3.83Jun 15 • IXHL $3.67

Will this trial show a positive result on change in apnea-hypopnea index (AHI), Phase 3?

Paper Trading
Create account to trade
Scientific editorial illustration for Obstructive Sleep Apnea

Obstructive Sleep Apnea

Obstructive sleep apnea blocks breathing repeatedly during sleep, causing poor sleep and drops in blood oxygen. Lower apnea-hypopnea index means fewer breathing pauses each hour, which can support safer, more restful sleep.

1Global burden: About 425 million adults2U.S. burden: About 54 million adults3Undiagnosed cases: 80% to 90%